Amendment To The Agreement Sample Contracts

- 2 - 4. Amendments to Existing Credit Agreement. A. Section 1.1 of the Existing Credit Agreement Is Hereby Amended by Adding the Following Definitions in the Appropriate Alphabetical Order: "Anti-Money Laundering Laws" Means Any and All Laws, Statutes, Regulations or Obligatory Government Orders, Decrees, Ordinances or Rules Applicable to a Credit Party, Its Subsidiaries or Affiliates Related to Terrorism Financing or Money Laundering, Including Any Applicable Provision of the PATRIOT Act and the Currency and Foreign Transactions Reporting Act (Also Known as the "Bank Secrecy Act," 31 U.S.C. (June 2nd, 2017)
Athenex, Inc. – First Amendment to the Agreement for Medical Technology Research, Development, Innovation and Commercialization Alliance (May 12th, 2017)

This FIRST AMENDMENT TO THE AGREEMENT FOR MEDICAL TECHNOLOGY RESEARCH, DEVELOPMENT, INNOVATION AND COMMERCIALIZATION ALLIANCE (First Amendment) is effective as of July 21, 2015, (First Amendment Effective Date) and is between FORT SCHUYLER MANAGEMENT CORPORATION (FSMC), a not-for-profit corporation existing under the laws of the State of New York, having its office located at 257 Fuller Road, Albany, New York 12203 and KINEX PHARMACEUTICALS, INC. (KINEX), a Delaware corporation with its principal office located at 701 Ellicott Street, Buffalo, New York 14203. Capitalized terms used but not defined in this First Amendment shall have the meanings set forth in the Agreement (as defined below).

Athenex, Inc. – Second Amendment to the Agreement for Medical Technology Research, Development, Innovation and Commercialization Alliance (May 12th, 2017)

This SECOND AMENDMENT TO THE AGREEMENT FOR MEDICAL TECHNOLOGY RESEARCH, DEVELOPMENT, INNOVATION AND COMMERCIALIZATION ALLIANCE (Second Amendment) is effective as of June 22, 2016, (Second Amendment Effective Date) and is between FORT SCHUYLER MANAGEMENT CORPORATION (FSMC), a not-for-profit corporation existing under the laws of the State of New York, having its office located at 257 Fuller Road, Albany, New York 12203 and ATHENEX, INC. (ATHENEX), a Delaware corporation with its principal office located at 1001 Main Street, Suite 600, Buffalo, New York 14203. Capitalized terms used but not defined in this Second Amendment shall have the meanings set forth in the Agreement (as defined below).

Athenex, Inc. – First Amendment to the Agreement for Medical Technology Research, Development, Innovation and Commercialization Alliance (May 1st, 2017)

This FIRST AMENDMENT TO THE AGREEMENT FOR MEDICAL TECHNOLOGY RESEARCH, DEVELOPMENT, INNOVATION AND COMMERCIALIZATION ALLIANCE (First Amendment) is effective as of July 21, 2015, (First Amendment Effective Date) and is between FORT SCHUYLER MANAGEMENT CORPORATION (FSMC), a not-for-profit corporation existing under the laws of the State of New York, having its office located at 257 Fuller Road, Albany, New York 12203 and KINEX PHARMACEUTICALS, INC. (KINEX), a Delaware corporation with its principal office located at 701 Ellicott Street, Buffalo, New York 14203. Capitalized terms used but not defined in this First Amendment shall have the meanings set forth in the Agreement (as defined below).

Athenex, Inc. – Second Amendment to the Agreement for Medical Technology Research, Development, Innovation and Commercialization Alliance (May 1st, 2017)

This SECOND AMENDMENT TO THE AGREEMENT FOR MEDICAL TECHNOLOGY RESEARCH, DEVELOPMENT, INNOVATION AND COMMERCIALIZATION ALLIANCE (Second Amendment) is effective as of June 22, 2016, (Second Amendment Effective Date) and is between FORT SCHUYLER MANAGEMENT CORPORATION (FSMC), a not-for-profit corporation existing under the laws of the State of New York, having its office located at 257 Fuller Road, Albany, New York 12203 and ATHENEX, INC. (ATHENEX), a Delaware corporation with its principal office located at 1001 Main Street, Suite 600, Buffalo, New York 14203. Capitalized terms used but not defined in this Second Amendment shall have the meanings set forth in the Agreement (as defined below).

Amendment to the Agreements Executed by and Between Redbanc S.A and Itau Corpbanca (April 13th, 2017)

In the City of Santiago de Chile, on October 11, ITAU CORPBANCA, Rut (Taxpayers ID) No. 97.023.000-9, represented by Javier Parra Benavente, holder of Identity Card No. 13.065.818-1, and by Walter Krefft Moreno, holder of Identity Card No. 8.526.346-3, all of them domiciled at Rosario Norte No. 660, in Las Condes, Metropolitan Region, hereinafter also referred to as the BANK, as parties of the first part; and REDBANC S.A., Rut(Taxpayers ID) No. 96.521.680-4, duly represented as it shall be hereinafter evidenced, by Felix Marin Donoso, holder of identity card number 8.546.457-4, and Cecilia Rojas Alarcon, holder of identity card number 7.871.719-5, all of them domiciled to the effects hereto at Huerfanos No. 770, Floor 12, in the commune and city of Santiago, hereinafter referred to as REDBANC, have agreed on the following amendments to the Agreements listed below.

Li3 Energy, Inc. – AMENDMENT TO THE AGREEMENT DATED AUGUST 30th, 2016 (October 11th, 2016)

LI3 ENERGY INC. (hereinafter, "Li3" and together with MSB, the "Parties"), a company duly incorporated under the laws of the State of Nevada, United States of America.

TiGenix NV – AMENDMENT TO THE AGREEMENT FOR THE ASSIGNMENT OF RIGHTS TO EXPLOIT IP BETWEEN THE UNIVERSIDAD AUTONOMA DE MADRID AND CELLERIX, S.L., OF NOVEMBER 3rd, 2004 (December 22nd, 2015)

Of the one part, the Excellent Mr. Angel Gabilondo Pujol, Magnificent Rector of the Universidad Autonoma de Madrid, located at the Ciudad Universitaria de Cantoblanco, C/ Einstein, 3, 28049 Madrid, in the name and on behalf of said University, and pursuant to the powers conferred to him by virtue of his office;

Biotie Therapies Corp. – Whereas: On 23 May 2007 BioTie and Lundbeck Entered Into License and Commercialisation Agreement (Hereinafter the Agreement) Regarding the Commercialisation of Nalmefene, a Specific Opioid Receptor Antagonist Developed by BioTie and Its Collaborators for the Treatment of Substance Abuse Disorders Such as Alcoholism and Obsessive Compulsive Disorders, Including but Not Limited to Pathological Gambling. Whereas: With This Second Amendment to the Agreement (Hereinafter the Amendment) the Parties Desire to Extend the Geographical Territory of Lundbecks Rights Under the Agreement to Cover Also the (May 14th, 2015)
Biotie Therapies Corp. – Whereas: On 23 May 2007 BioTie and Lundbeck Entered Into License and Commercialisation Agreement (Hereinafter the Agreement) Regarding the Commercialisation of Nalmefene, a Specific Opioid Receptor Antagonist Developed by BioTie and Its Collaborators for the Treatment of Substance Abuse Disorders Such as Alcoholism and Obsessive Compulsive Disorders, Including but Not Limited to Pathological Gambling. Whereas: With This First Amendment to the Agreement (Hereinafter the Amendment) the Parties Desire to Extend the Geographical Territory of Lundbecks Rights Under the Agreement to Cover Also Unite (May 14th, 2015)
Biotie Therapies Corp. – Whereas: On 23 May 2007 BioTie and Lundbeck Entered Into a License and Commercialisation Agreement (Hereinafter the Agreement) Regarding the Commercialisation and Continued Development of Nalmefene, a Specific Opioid Receptor Antagonist Initially Developed by BioTie and Its Collaborators for the Treatment of Substance Abuse Disorders Such as Alcoholism and Obsessive Compulsive Disorders, Including but Not Limited to Pathological Gambling. Whereas: With This Sixth Amendment to the Agreement (Hereinafter the Amendment) the Parties Wish to Change the Agreed Royalty Rates. (May 14th, 2015)
First Amendment to the Agreement (May 14th, 2015)

This First Amendment to the Agreement ("Amendment") is effective as of March 13, 2015 ("Effective Date"), by and between Infinite Group, Inc. ("IGI") and the Pension Benefit Guaranty Corporation ("PBGC"), a United States government corporation.

Biotie Therapies Corp. – Whereas: On 23 May 2007 BioTie and Lundbeck Entered Into a License and Commercialisation Agreement (Hereinafter the Agreement) Regarding the Commercialisation of Nalmefene, a Specific Opioid Receptor Antagonist Developed by BioTie and Its Collaborators for the Treatment of Substance Abuse Disorders Such as Alcoholism and Obsessive Compulsive Disorders, Including but Not Limited to Pathological Gambling. Whereas: With This Third Amendment to the Agreement (Hereinafter the Amendment) the Parties Desire to Extend the Geographical Territory of Lundbecks Rights Under the Agreement to Cover Also the (May 14th, 2015)
Amyris – Confidential Treatment Requested. Certain Portions of This Document Have Been Omitted Pursuant to a Request for Confidential Treatment And, Where Applicable, Have Been Marked With an Asterisk to Denote Where Omissions Have Been Made. The Confidential Material Has Been Filed Separately With the Securities and Exchange Commission. Third Amendment to the Agreement for the Supply of Sugarcane Juice and Other Utilities (May 7th, 2015)

I- AMYRIS BRASIL LTDA , a limited liability company, based in the city of Campinas, State of Sao Paulo, at Rua James Clerk Maxwell, no. 315-Techno Park, ZIP CODE: 13069-380, duly entered in the National Register of Legal Entities of the Ministry of Finance - CNPJ/MF under no. 09,379,224/0001-20, herein represented in accordance with its Bylaws, hereinafter designated simply "AMYRIS"; and, on the other hand,

Biotie Therapies Corp. – Whereas: On 23 May 2007 BioTie and Lundbeck Entered Into a License and Commercialisation Agreement (Hereinafter the Agreement) Regarding the Commercialisation and Continued Development of Nalmefene, a Specific Opioid Receptor Antagonist Initially Developed by BioTie and Its Collaborators for the Treatment of Substance Abuse Disorders Such as Alcoholism and Obsessive Compulsive Disorders, Including but Not Limited to Pathological Gambling. Whereas: With This Sixth Amendment to the Agreement (Hereinafter the Amendment) the Parties Wish to Change the Agreed Royalty Rates. (April 21st, 2015)
Biotie Therapies Corp. – Whereas: On 23 May 2007 BioTie and Lundbeck Entered Into License and Commercialisation Agreement (Hereinafter the Agreement) Regarding the Commercialisation of Nalmefene, a Specific Opioid Receptor Antagonist Developed by BioTie and Its Collaborators for the Treatment of Substance Abuse Disorders Such as Alcoholism and Obsessive Compulsive Disorders, Including but Not Limited to Pathological Gambling. Whereas: With This Second Amendment to the Agreement (Hereinafter the Amendment) the Parties Desire to Extend the Geographical Territory of Lundbecks Rights Under the Agreement to Cover Also the (April 21st, 2015)
Biotie Therapies Corp. – Whereas: On 23 May 2007 BioTie and Lundbeck Entered Into a License and Commercialisation Agreement (Hereinafter the Agreement) Regarding the Commercialisation of Nalmefene, a Specific Opioid Receptor Antagonist Developed by BioTie and Its Collaborators for the Treatment of Substance Abuse Disorders Such as Alcoholism and Obsessive Compulsive Disorders, Including but Not Limited to Pathological Gambling. Whereas: With This Third Amendment to the Agreement (Hereinafter the Amendment) the Parties Desire to Extend the Geographical Territory of Lundbecks Rights Under the Agreement to Cover Also the (April 21st, 2015)
Biotie Therapies Corp. – Whereas: On 23 May 2007 BioTie and Lundbeck Entered Into License and Commercialisation Agreement (Hereinafter the Agreement) Regarding the Commercialisation of Nalmefene, a Specific Opioid Receptor Antagonist Developed by BioTie and Its Collaborators for the Treatment of Substance Abuse Disorders Such as Alcoholism and Obsessive Compulsive Disorders, Including but Not Limited to Pathological Gambling. Whereas: With This First Amendment to the Agreement (Hereinafter the Amendment) the Parties Desire to Extend the Geographical Territory of Lundbecks Rights Under the Agreement to Cover Also Unite (April 21st, 2015)
Fourth Amendment to Employment Agreement (April 10th, 2015)

WHEREAS, Amtech Systems, Inc. (the "Company") and Fokko Pentinga (the "Executive") entered into an Employment Agreement dated June 29, 2012 (with all subsequent amendments thereto, the "Agreement"); and

Constellation Energy Prtnrs – Amendment No. 1 to the Agreement of Limited Partnership of Sanchez Production Partners Lp (April 1st, 2015)

This Amendment No. 1 (this "Amendment") to the Agreement of Limited Partnership of Sanchez Production Partners LP, a Delaware limited partnership (the "Partnership"), dated as of March 6, 2015 (the "Partnership Agreement"), is entered into effective as of March 31, 2015 at the direction of Sanchez Production Partners GP LLC, as the general partner of the Partnership (the "General Partner"), pursuant to authority granted to it in Section 13.1 of the Partnership Agreement. Capitalized terms used but not defined herein have the meanings ascribed to them in the Partnership Agreement.

The AGREEMENT FOR SERVICES RELATED TO KALBITOR(r) BY AND BETWEEN DYAX CORP. AND WALGREENS INFUSION SERVICES, INC. THIS SECOND AMENDMENT TO THE AGREEMENT FOR SERVICES RELATED TO KALBITOR(r) (February 27th, 2015)

(the "Amendment") is made and entered into as of the 30th day of September 2013 (the "Second Amendment Effective Date"), by and between DYAX CORP., a Delaware corporation ("Dyax"), and WALGREENS INFUSION SERVICES, INC., a Delaware corporation ("Walgreens"), to amend that certain Agreement For Services Related to Kalbitor, effective as of September 1, 2011, entered into by and between Dyax and Walgreens, as modified by that certain First Amendment dated as of August 31, 2012 (collectively, the "Agreement"). Capitalized terms used herein which are not defined shall have the meanings given to them in the Agreement.

Revolutionary Concepts – Amendment to the Agreement Between Revolutionary Concepts, Inc. And Eyetalk365, Llc (February 13th, 2015)

THIS AMENDMENT (hereinafter Amendment) is made and entered into effective September 16, 2014 (Amendment Effective Date), by and between Revolutionary Concepts, Inc., a Nevada corporation having an address at 1914 JN Pease Place, Charlotte, NC 28262 (Licensor), and Eyetalk365, LLC, a North Carolina limited liability corporation having an address at 9923 Willow Leaf Lane, Cornelius, NC 28031 (Licensee).

Amendment to the Agreement Relating to Acquistions (December 11th, 2014)

THIS AMENDMENT TO THE AGREEMENT RELATING TO ACQUISITIONS (this Amendment) is made and entered into effective as of the 1st day of September, 2014, by and between the Sea Ray Division of Brunswick Corporation (the Company), and MarineMax, Inc. (MarineMax).

TiGenix NV – AMENDMENT TO THE AGREEMENT FOR THE ASSIGNMENT OF RIGHTS TO EXPLOIT IP BETWEEN THE UNIVERSIDAD AUTONOMA DE MADRID AND CELLERIX, S.L., OF NOVEMBER 3rd, 2004 (November 19th, 2014)

Of the one part, the Excellent Mr. Angel Gabilondo Pujol, Magnificent Rector of the Universidad Autonoma de Madrid, located at the Ciudad Universitaria de Cantoblanco, C/ Einstein, 3, 28049 Madrid, in the name and on behalf of said University, and pursuant to the powers conferred to him by virtue of his office;

California Resources Corp – Amendment to the Agreement for Implementation of an Optimized Waterflood Program for the Long Beach Unit (August 20th, 2014)

THIS AMENDMENT TO THE AGREEMENT FOR IMPLEMENTATION OF AN OPTIMIZED WATERFLOOD PROGRAM FOR THE LONG BEACH UNIT (this Amendment) is made and entered into as of the 16 day of January, 2009, by and among the State of California (the State), by and through the State Lands Commission ( the SLC), the City of Long Beach (the City), and Oxy Long Beach, Inc. (OLBI), collectively referred to herein as the Parties.

First Amendment to the Agreement and Plan of Merger (August 15th, 2014)

This FIRST AMENDMENT TO THE AGREEMENT AND PLAN OF MERGER, dated as of August 14, 2014 (this "Amendment"), is made by and among FortisUS Inc., a Delaware corporation ("Parent"), Color Acquisition Sub Inc., an Arizona corporation and a wholly-owned subsidiary of Parent ("Merger Sub"), and UNS Energy Corporation, an Arizona corporation (the "Company"). All capitalized terms used but not defined herein shall have the meanings specified in the Merger Agreement (as defined below).

Third Amendment to the Agreement for Distribution of Products (June 11th, 2014)

The Agreement for Distribution of Products dated September 26, 2006 between Whole Foods Market Distribution, Inc., a Delaware corporation, and United Natural Foods, Inc., a Delaware corporation (the "Agreement") as amended by the First Amendment to the Agreement for Distribution of Products dated June 2, 2010, and the Second Amendment to the Agreement for Distribution of Products dated October 11, 2010, is hereby amended effective February 20, 2014.

Third Amendment to the Agreement for Distribution of Products (May 16th, 2014)

The Agreement for Distribution of Products dated September 26, 2006 between Whole Foods Market Distribution, Inc., a Delaware corporation, and United Natural Foods, Inc., a Delaware corporation (the "Agreement") as amended by the First Amendment to the Agreement for Distribution of Products dated June 2, 2010, and the Second Amendment to the Agreement for Distribution of Products dated October 11, 2010, is hereby amended effective February 20, 2014.

Crescent Financial Corporation – First Amendment to the Agreement and Plan of Merger (April 25th, 2014)

This FIRST AMENDMENT TO THE AGREEMENT AND PLAN OF MERGER, dated April 22, 2014 (this "Amendment") amends that certain Agreement and Plan of Merger (the "Merger Agreement"), dated as of January 27, 2014, by and among Yadkin Financial Corporation ("Yadkin"), VantageSouth Bancshares, Inc. ("VantageSouth"), and Piedmont Community Bank Holdings, Inc. ("Piedmont"), pursuant to which VantageSouth and Piedmont will each merge with and into Yadkin.

Yadkin Financial – First Amendment to the Agreement and Plan of Merger (April 25th, 2014)

This FIRST AMENDMENT TO THE AGREEMENT AND PLAN OF MERGER, dated April 23, 2014 (this Amendment) amends that certain Agreement and Plan of Merger (the Merger Agreement), dated as of January 27, 2014, by and among Yadkin Financial Corporation (Yadkin), VantageSouth Bancshares, Inc. (VantageSouth), and Piedmont Community Bank Holdings, Inc. (Piedmont), pursuant to which VantageSouth and Piedmont will each merge with and into Yadkin.

Investors Bancorp, Inc. – First Amendment to the Agreement and Plan of Merger (December 3rd, 2013)

This Amendment to the Agreement and Plan of Merger, dated as of November 27, 2013 ("First Amendment"), by and among (i) Investors Bank, a New Jersey savings bank ("Investors Bank"), Investors Bancorp, Inc., a Delaware corporation ("Investors Bancorp"), and Investors Bancorp, MHC, a New Jersey mutual holding company ("Investors MHC"), and (ii) GCF Bank, a Federal savings bank, Gateway Community Financial Corp, a Federal corporation ("Gateway Community"), and Gateway Community Financial, MHC, a Federal mutual holding company ("Gateway MHC"). Each of Investors Bank, Investors Bancorp, and Investors MHC are sometimes referred to herein as the "Investors Parties," and each of GCF Bank, Gateway Community and Gateway MHC are sometimes referred to herein as the "Gateway Parties." All capitalized terms contained in this Amendment, but not specifically defined in this Amendment, shall have the meanings ascribed to such terms in the Agreement.

Roma Financial Corporation – Second Amendment to the Agreement and Plan of Merger (December 3rd, 2013)

THIS AMENDMENT TO THE AGREEMENT AND PLAN OF MERGER, dated as of November 27, 2013 ("Second Amendment"), by and among (i) Investors Bank, a New Jersey savings bank ("Investors Bank"), Investors Bancorp, Inc., a Delaware corporation ("Investors Bancorp"), and Investors Bancorp, MHC, a New Jersey mutual holding company ("Investors MHC"), and (ii) Roma Bank, a Federal savings bank, Roma Financial Corporation, a Federal corporation ("Roma Financial"), and Roma Financial, MHC, a Federal mutual holding company ("Roma MHC"). Each of Investors Bank, Investors Bancorp, and Investors MHC are sometimes referred to herein as the "Investors Parties," and each of Roma Bank, Roma Financial and Roma MHC are sometimes referred to herein as the "Roma Parties." All capitalized terms contained in this Amendment, but not specifically defined in this Amendment, shall have the meanings ascribed to such terms in the Agreement.

Investors Bancorp, Inc. – Second Amendment to the Agreement and Plan of Merger (December 3rd, 2013)

This Amendment to the Agreement and Plan of Merger, dated as of November 27, 2013 ("Second Amendment"), by and among (i) Investors Bank, a New Jersey savings bank ("Investors Bank"), Investors Bancorp, Inc., a Delaware corporation ("Investors Bancorp"), and Investors Bancorp, MHC, a New Jersey mutual holding company ("Investors MHC"), and (ii) Roma Bank, a Federal savings bank, Roma Financial Corporation, a Federal corporation ("Roma Financial"), and Roma Financial, MHC, a Federal mutual holding company ("Roma MHC"). Each of Investors Bank, Investors Bancorp, and Investors MHC are sometimes referred to herein as the "Investors Parties," and each of Roma Bank, Roma Financial and Roma MHC are sometimes referred to herein as the "Roma Parties." All capitalized terms contained in this Amendment, but not specifically defined in this Amendment, shall have the meanings ascribed to such terms in the Agreement.

Mtr Gaming Group – Third Amendment to Employment Agreement (November 5th, 2013)

THIS THIRD AMENDMENT TO EMPLOYMENT AGREEMENT dated this 30th day of October, 2013 (this Third Amendment), by and between MTR Gaming Group, Inc., a Delaware corporation (MTR), and Joseph L. Billhimer, an adult individual (the Executive) (collectively the Parties).

Roma Financial Corporation – First Amendment to the Agreement and Plan of Merger (September 27th, 2013)

THIS AMENDMENT TO THE AGREEMENT AND PLAN OF MERGER, dated as of September 26 2013 ("First Amendment"), by and among (i) Investors Bank, a New Jersey savings bank ("Investors Bank"), Investors Bancorp, Inc., a Delaware corporation ("Investors Bancorp"), and Investors Bancorp, MHC, a New Jersey mutual holding company ("Investors MHC"), and (ii) Roma Bank, a Federal savings bank, Roma Financial Corporation, a Federal corporation ("Roma Financial"), and Roma Financial, MHC, a Federal mutual holding company ("Roma MHC"). Each of Investors Bank, Investors Bancorp, and Investors MHC are sometimes referred to herein as the "Investors Parties," and each of Roma Bank, Roma Financial and Roma MHC are sometimes referred to herein as the "Roma Parties." All capitalized terms contained in this Amendment, but not specifically defined in this Amendment, shall have the meanings ascribed to such terms in the Agreement.